Reply to Dr. Lonsdale

Townsend Letter for Doctors and Patients, August-Sept, 2004 by Traj P.S. Nibber

9. Geyer J, Netzel M, Bitsch I, Frank T, Bitsch R, Kramer K, Hoppe P. Bioavailability of water- and lipid-soluble thiamin compounds in broiler chickens. Int J Vitam Nutr Res. 2000 Dec;70(6):311-6.

10. Frank T, Bitsch R, Maiwald J, Stein G. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfotiamine. Eur J Clin Pharmacol. 20 Jun;56(3):251-7.

11. Frank T, Bitsch R, Maiwald J, Stein G. Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD). Int J Clin Pharmacol Ther. 1999 Sep;37(9):449-55.

12. Greb A, Bitsch R. Comparative bioavailability of various thiamine derivatives after oral administration. Int J Clin Pharmacol Ther. 1998 Apr;36(4):216-21.

13. Shindo H, Okamoto K, Totsu J. Transport of organic compounds through biological membranes. I. Accumulative uptake of S-benzoylthiamine by human erythrocytes. Chem Pharm Bull (Tokyo). 1967 Mar;15(3):295-302.

14. Yamamoto J, Kaneda Y. Excretion of intracorporeal cadmium with S-benzoylthiamin monophosphate. Bull Environ Contam Toxicol. 1995 May;54(5):745-50.

Dr. Traj P.S. Nibber, Director

Advanced Orthomolecular Research